about
Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancersMolecular Targets and Emerging Therapeutic Options for Uterine LeiomyosarcomaMenopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trialsEndometrial Expression of Steroidogenic Factor 1 Promotes Cystic Glandular Morphogenesis.On the reproducibility of TCGA ovarian cancer microRNA profiles.Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.Discovery of novel microRNAs in female reproductive tract using next generation sequencing.A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancerFunctional microRNA involved in endometriosis.Relaxin signaling in uterine fibroids.TGFβ signaling promotes juvenile granulosa cell tumorigenesis by suppressing apoptosis.Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies.Prospective evaluation of insulin resistance among endometrial cancer patientsUterine cysts in female mice deficient for caveolin-1 and insulin-like 3 receptor RXFP2Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.XMRF: an R package to fit Markov Networks to high-throughput genetics data.Dual targeting of mTOR and aurora-A kinase for the treatment of uterine Leiomyosarcoma.Pregnancy Increases Relaxation in Human Omental Arteries to the CGRP Family of Peptides.MicroRNAs and Recent Insights into Pediatric Ovarian Cancers.Novel MicroRNAs regulating proliferation and apoptosis in uterine papillary serous carcinomas.Alveolar soft part sarcoma of the cervix: case report and literature review.A role for BRCA1 in uterine leiomyosarcoma.Juvenile granulosa cell ovarian tumor: a case report and review of literature.Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experiencePreferences and Outcomes for Chemotherapy Teaching in a Postgraduate Obstetrics and Gynecology Training Program.A retrospective evaluation of furosemide and mannitol for prevention of cisplatin-induced nephrotoxicity.Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS.Treatment Compliance and Outcomes for Women With Locoregionally Advanced Cervical Cancer Treated in a Safety Net Health System.Prognostic value of endocervical sampling following loop excision of high grade intraepithelial neoplasia.Implementing targeted cervical cancer screening videos at the point of care.The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy.MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.Pyomyoma after uterine artery embolization.Acceptability of self-sample human papillomavirus testing among medically underserved women visiting the emergency department.Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer.Balloon tamponade of hemorrhage after uterine curettage for gestational trophoblastic disease.Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women's Health Initiative.Outcomes of Planned Compared With Urgent Deliveries Using a Multidisciplinary Team Approach for Morbidly Adherent Placenta.A Role for Progesterone-Regulated sFRP4 Expression in Uterine Leiomyomas.Trans10,cis12 conjugated linoleic acid inhibits proliferation and migration of ovarian cancer cells by inducing ER stress, autophagy, and modulation of Src.
P50
Q24634248-3CA09D62-DE6F-4025-B0AA-1AD240E67838Q28076023-E7048B35-AF84-4246-B2FC-E1FC21A415C8Q28392391-CEA6394B-8FFC-4103-8B0D-C7C07A70646BQ30353001-E0AF2E67-AC20-4634-8B8B-B87D9B332ACAQ31149803-95506D84-766C-411E-920E-1042D718168EQ33424526-B158288D-0687-4CBB-96BA-49A5FB96B4BBQ33540195-F12C2752-8CEE-4615-9D25-B337FE4549D0Q33634277-F280C62B-1CFC-491E-9C4B-E52B40047B06Q34173197-57077EE5-3800-4CBF-BBA8-57B01275E5ABQ34197050-D09BCC7B-5BF1-4576-BF4A-76A300C72418Q34422499-411D44F0-48AB-4737-9910-F73C95C9922FQ34501316-B5307B6B-0274-4BDE-B902-2FC8F83D096AQ34859018-A2726271-EFF3-4F75-87ED-679ECD33A26AQ35001368-EE72183A-A010-4983-8E69-AEC66343819DQ35116008-BFE80535-65AF-4199-96F1-18833A568CBCQ36120544-49A2C49F-CBCB-4C0D-BED6-8B054FE765DBQ36205257-98641CCA-BAFE-4B43-9C87-436C587DAF3BQ36461988-F2A9D9CC-137D-4309-8373-32CFA81137A1Q36804155-4F468BE8-17AA-4CD0-B9ED-34F59B94E423Q36893313-58A4CCE0-A93B-4B7C-85FE-6FB0EBF17220Q37189402-98A6735E-5E9F-4EA4-B6AB-1753A07486E2Q37440983-5C112385-EDCC-45A0-82E6-117263DCE463Q37540857-7541C46A-E7A0-4A03-A188-2BAAFD760720Q37553880-4204D051-66A1-4ED1-9697-5781091EA3C3Q38539497-2FED11E1-D02C-42D0-81CB-E271115B0F7BQ38919157-57678BFC-161F-4A7B-B60D-E0A7F498F18BQ38950665-7AD6AB03-A311-4459-B772-0AFFD0C15B99Q38974684-67D9FB29-839D-4ED7-ACC9-AEFB4044398EQ39024068-34BB3546-FCE9-41E7-A87B-817ACA1DD58CQ39120978-2474004E-9A8A-4B23-8ED7-8442BFC722A7Q39174528-C1FB4342-2401-40C6-9492-35948F4F9366Q39393414-2BCB90D0-E7A6-4FE8-BFF0-0F0BD1B0AC24Q40259115-9DBA6465-391F-4E32-8EA4-7C61EE99F1D3Q40284466-FDC1911A-92BB-4209-8626-07E2D4723ADEQ40395668-A813EB90-EA21-4354-912E-1D3606389989Q46155780-4613A648-0CD0-44B5-96E2-A619D5EE8069Q46180967-8B4DC464-A74D-4A85-BFF3-D2C43E5C634FQ47659730-70B8F893-1A8E-4ECE-985C-2B9D36C06ACEQ47793478-FC7941BC-22F3-42B7-9FDF-E4326F86AE85Q48260059-3742BFE0-76E6-4A1C-859F-588307E7157C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Matthew L Anderson
@nl
Matthew L Anderson
@sl
Matthew L. Anderson
@en
Matthew L. Anderson
@es
type
label
Matthew L Anderson
@nl
Matthew L Anderson
@sl
Matthew L. Anderson
@en
Matthew L. Anderson
@es
prefLabel
Matthew L Anderson
@nl
Matthew L Anderson
@sl
Matthew L. Anderson
@en
Matthew L. Anderson
@es
P106
P1153
56399834500
P21
P2456
P31
P496
0000-0002-2081-4672